Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.68 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 2/20 | 0.51 |
| ▸ | GFER | P55789 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.48 |
| ▸ | GLS | O94925 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5261845 | 0.86 | TSHR (0.64) | TSHRMAPTGAAGFERLMNA | |
| SCHEMBL28907376 | 0.84 | BRD4 (0.68) | BRD4TSHRMAPTNPC1GAA | |
| SCHEMBL30910867 | 0.81 | BRD4 (0.86) | BRD4TSHRMAPTNPC1LMNA | |
| SCHEMBL1168830 | 0.79 | HSD17B13 (0.53) | BRD4TSHRMAPTGAAGFER | |
| SCHEMBL27492257 | 0.78 | BRD4 (0.58) | BRD4TSHRMAPTRXFP1L3MBTL1 | |
| SCHEMBL22734270 | 0.77 | TSHR (0.58) | TSHRMAPTGAAGFERLMNA | |
| SCHEMBL29922633 | 0.77 | BRD4 (0.79) | BRD4TSHRMAPTNPC1GAA | |
| SCHEMBL21830986 | 0.77 | BRD4 (0.79) | BRD4TSHRMAPTNPC1GAA | |
| SCHEMBL12660312 | 0.76 | BRD4 (0.68) | BRD4TSHRMAPTNPC1LMNA | |
| SCHEMBL29694632 | 0.75 | BRD4 (0.76) | BRD4TSHRMEN1KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115066427-A | Compound, organic electroluminescent device and display device | SK株式会社 | 2022-09-16 | — | — | CN | disclosed |
| WO-2021132952-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND DISPLAY DEVICE | 에스케이머티리얼즈 주식회사 | 2021-07-01 | — | — | WO | disclosed |
| US-20210143337-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE | SK MATERIALS CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
| US-20210143337-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE | SK MATERIALS CO., LTD. (KR) | 2021-05-13 | — | — | US | disclosed |
| CN-112262144-A | Compound, organic electroluminescent device and display device | SK材料有限公司 | 2021-01-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210143337-A1 | COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE | L1CAM, EML4, OCIAD2 | BRD4 2854/4885TSHR 4181/4885MAPT 1664/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.